Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caryl E Sortwell

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Strategies for the augmentation of grafted dopamine neuron survivalCaryl E Sortwell
Neurobiology of Disease|June 28, 2022
Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicityAnna C Stoll, Caryl E Sortwell
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2018
BDNF provides many routes toward STN DBS-mediated disease modificationD Luke Fischer, Caryl E Sortwell
NPJ Parkinson'S Disease|April 13, 2021
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factorKathryn M Miller, Natosha M Mercado, Caryl E Sortwell
Annals of the New York Academy of Sciences|July 9, 2003
Cellular models to study dopaminergic injury responsesTimothy J Collier, Kathy Steece-Collier, Susan McGuire, et al.
The European Journal of Neuroscience|March 16, 2012
Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian ratLalitha Madhavan, Brian F Daley, Caryl E Sortwell, et al.
Cell Transplantation|June 12, 2004
Reassessment of caspase inhibition to augment grafted dopamine neuron survivalDeanna M Marchionini, Timothy J Collier, Mark R Pitzer, et al.
Experimental Neurology|April 15, 2004
An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionalityCaryl E Sortwell, Timothy J Collier, Maria D Camargo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2019
Cell therapy for Parkinson's disease: Why it doesn't work every timeTimothy J Collier, Caryl E Sortwell, Natosha M Mercado, et al.
Journal of Visualized Experiments : Jove|March 8, 2021
Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's DiseaseNatalie Landeck, Melissa Conti Mazza, Megan Duffy, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Strategies for the augmentation of grafted dopamine neuron survivalCaryl E Sortwell
Neurobiology of Disease|June 28, 2022
Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicityAnna C Stoll, Caryl E Sortwell
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2018
BDNF provides many routes toward STN DBS-mediated disease modificationD Luke Fischer, Caryl E Sortwell
NPJ Parkinson'S Disease|April 13, 2021
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factorKathryn M Miller, Natosha M Mercado, Caryl E Sortwell
Annals of the New York Academy of Sciences|July 9, 2003
Cellular models to study dopaminergic injury responsesTimothy J Collier, Kathy Steece-Collier, Susan McGuire, et al.
The European Journal of Neuroscience|March 16, 2012
Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian ratLalitha Madhavan, Brian F Daley, Caryl E Sortwell, et al.
Cell Transplantation|June 12, 2004
Reassessment of caspase inhibition to augment grafted dopamine neuron survivalDeanna M Marchionini, Timothy J Collier, Mark R Pitzer, et al.
Experimental Neurology|April 15, 2004
An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionalityCaryl E Sortwell, Timothy J Collier, Maria D Camargo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2019
Cell therapy for Parkinson's disease: Why it doesn't work every timeTimothy J Collier, Caryl E Sortwell, Natosha M Mercado, et al.
Journal of Visualized Experiments : Jove|March 8, 2021
Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's DiseaseNatalie Landeck, Melissa Conti Mazza, Megan Duffy, et al.
Pageof 8